Cancer remains the dominant disease target for biotech through to 2010

Author: Pijpers Fleur   Belsey Mark J  

Publisher: Palgrave Macmillan Ltd

ISSN: 1478-565X

Source: Journal of Commercial Biotechnology, Vol.12, Iss.4, 2006-07, pp. : 294-298

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract